Menu Search
Equities

Glass House Brands Inc

GLASF:QXE

Glass House Brands Inc

Actions
  • Price (USD)8.67
  • Today's Change0.082 / 0.95%
  • Shares traded6.66k
  • 1 Year change+193.90%
  • Beta--
Data delayed at least 15 minutes, as of Apr 24 2024 14:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Glass House Brands Inc. is a vertically integrated cannabis company. The Company, through its subsidiaries, cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods (CPG) to third-party retail stores in the state of California. The Company also owns and operates retail cannabis stores in the state of California. Its products include raw cannabis, cannabis oil and cannabis CPG. Its portfolio of brands includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. Its retail landscape consists of approximately nine stores across California, including The Pottery, Farmacy and natural healing center (NHC). The Company’s Farmacy branded dispensaries are located in Santa Barbara, Santa Ana and Berkeley, California. It operates multiple greenhouse cultivation facilities located in Carpinteria and Camarillo, California, and its manufacturing production facilities are located in Lompoc, California.

  • Revenue in USD (TTM)160.84m
  • Net income in USD-98.27m
  • Incorporated2019
  • Employees362.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		 since
announced		Transaction
value
Natural Healing Center Dispensary,Turlock,CaliforniaDeal completed25 Apr 202325 Apr 2023Deal completed192.83%--
Data delayed at least 30 minutes, as of Apr 23 2024.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.